CITIUS ONCOLOGY, INC. Quarterly Assets in USD from Q4 2021 to Q3 2024

Taxonomy & unit: us-gaap: USD
Description: Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
Summary: Citius Oncology, Inc. quarterly Assets history and growth rate from Q4 2021 to Q3 2024.
Citius Oncology, Inc. Assets for the quarter ending September 30, 2024 was $84.4M, a 76.7% increase year-over-year.

Assets, Quarterly (USD)

Assets, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q3 2024	$84.4M	+$36.6M	+76.7%	Sep 30, 2024	10-K	2024-12-27
Q2 2024	$49.2M	-$20.7M	-29.6%	Jun 30, 2024	10-Q	2024-08-09
Q1 2024	$48.7M	-$20.1M	-29.3%	Mar 31, 2024	10-Q	2024-05-20
Q4 2023	$72.6M	+$4.43M	+6.5%	Dec 31, 2023	10-Q	2024-08-09
Q3 2023	$47.7M	+$47.5M	+18492%	Sep 30, 2023	10-K	2024-12-27
Q2 2023	$69.9M			Jun 30, 2023	10-Q	2023-08-16
Q1 2023	$68.8M			Mar 31, 2023	10-Q	2023-05-15
Q4 2022	$68.2M	+$68.1M	+53839%	Dec 31, 2022	10-K	2024-04-16
Q3 2022	$257K			Sep 30, 2022	10-Q	2022-11-28
Q4 2021	$126K			Dec 31, 2021	10-K	2023-04-17

* An asterisk sign (*) next to the value indicates that the value is likely invalid.